People · Operator

Linda Graebner

Named in public records as an officer, director or promoter · active 2013–2013 · Other Health Care

1
Companies
1
Filings
$47.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Solta Medical IncOther Health CareSeries B$47.5M$564.9M2013
Operator network

Linda Graebner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Mark Sieczkarek · 5 companies · 1 sharedMark SieczkarekClint Carnell · 4 companies · 1 sharedClint CarnellEric Stang · 4 companies · 1 sharedEric StangDavid Holthe · 3 companies · 1 sharedDavid HoltheCathy McCarthy · 2 companies · 1 sharedCathy McCarthyWilliam Brodie · 2 companies · 1 sharedWilliam BrodieDoug Heigel · 1 companies · 1 sharedDoug HeigelEdward Knowlton · 1 companies · 1 sharedEdward KnowltonHarold Covert · 1 companies · 1 sharedHarold CovertH. Daniel Ferrari · 1 companies · 1 sharedH. Daniel FerrariJeff Nardoci · 1 companies · 1 sharedJeff NardociJohn Glenn · 1 companies · 1 sharedJohn GlennLen DeBenedictis · 1 companies · 1 sharedLen DeBenedictisMarti Morfitt · 1 companies · 1 sharedMarti MorfittStephen Fanning · 1 companies · 1 sharedStephen FanningSolta Medical Inc · $47.5M raisedSolta Medical IncLinda GraebnerLG
Linda Graebner Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Linda Graebner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Mark Sieczkarek15
Clint Carnell14
Eric Stang14
David Holthe13
William Brodie12
Cathy McCarthy12
Stephen Fanning11
Harold Covert11
Edward Knowlton11
H. Daniel Ferrari11
Jeff Nardoci11
Len DeBenedictis11
John Glenn11
Marti Morfitt11
Doug Heigel11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.